VK Sharma of HDFC Securities told CNBC-TV18, "Although we would like to look at Sun Pharmaceutical Industries, there are no evidences there that the worst seems to be over at this point of time. So, in Lupin I am suggesting buying 1,750 Call at around Rs 40 with stop loss at Rs 30 and possible target of Rs 65. This is a stock, which appears to be doing better, has done well, so we think that at least this industry can continue to do well in an otherwise market doesn’t do that well."At 11:56 hrs Lupin was quoting at Rs 1,784, up Rs 27, or 1.54 percent. It has touched an intraday high of Rs 1,786.50 and an intraday low of Rs 1,760.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!